IgA nephropathy: open trials in Czechia

• NCT06963827

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  Trial Treatment · Phase 3 · Takeda

  Nemocnice AGEL Nový Jičín a.s., Nový Jičín · University Hospital Olomouc, Olomouc · Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-11-04

• 2024-519638-22-00

  A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-10-30

• NCT07773727

  A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN

  Trial Treatment · Phase 2 · argenx

  Fakultni nemocnice Hradec Kralove, Hradec Králové · Všeobecná fakultní nemocnice v Praze, Praha 2

  Registry updated 2026-10-27

• NCT07146906

  A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-10-21

• NCT06935357

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  Trial Treatment · Phase 3 · Biogen

  Vseobecna fakultni nemocnice v Praze, Prague · Institute for Clinical and Experimental Medicine, Prague

  Registry updated 2026-10-14

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-10-05

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error